Medtronic (MDT)

Koninklijke Philips N.V. (AMS:PHIA), commonly known as Philips, is one of the most storied companies in the history of European industry. Founded in 1891 in Eindhoven, Netherlands, Philips has evolved from a modest light bulb manufacturer into a global leader in health technology and medical innovation. Its transformation

If you're looking for high-yield stocks in the healthcare sector, it's hard to beat this trio of industry giants offering yields of up to 3.9%.

The Federal Circuit overturned a $106 Million verdict against Medtronic, ruling that Colibri was barred from claiming patent infringement.

These S&P 500 dividend stocks have fallen by up to 33% and are best buys now.

The move wiped out all of the gains Sarepta lodged Thursday after announcing its restructuring plans.

The company's second biggest product missed sales expectations. Shares look likely to undercut a buy zone.

The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.

MEDTRONIC PLC (NYSE:MDT) appears undervalued with strong profitability, a solid dividend, and stable financials, making it a candidate for value investors.

The company is also restructuring with the hopes of saving $400 million in expenses.

MEDTRONIC PLC (NYSE:MDT) offers a solid 3.18% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors. The company has a reliable payout history and decent financial health.

Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.

Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list.

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption.

A steady dose of quality companies will keep your portfolio growing big and strong.

Chad Spooner’s appointment will be effective July 14, and he will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives.

Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.